ArticleESMO gastrointestinal oncology2025

Regorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm phase II trial.

A El Kaddissi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.